{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:05:46Z","timestamp":1771509946870,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-37569-w","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:45:49Z","timestamp":1769597149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Talin1 is downregulated in testicular germ cell tumors according to combined bioinformatics and experimental approaches"],"prefix":"10.1038","volume":"16","author":[{"given":"Mahdieh","family":"Razmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayna","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somayeh","family":"Vafaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandana","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roya","family":"Ghods","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sima","family":"Saki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Madjd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leili","family":"Saeednejad Zanjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"37569_CR1","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3390\/ijms22031380","volume":"22","author":"M De Martino","year":"2021","unstructured":"De Martino, M., Chieffi, P. & Esposito, F. MiRNAs and biomarkers in testicular germ cell tumors: an update. Int. J. Mol. Sci. 22, 1380 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"37569_CR2","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. Ca 75, 10 (2025).","journal-title":"Ca"},{"key":"37569_CR3","first-page":"1","volume":"4","author":"L Cheng","year":"2018","unstructured":"Cheng, L. et al. Testicular cancer. Nat. Reviews Disease Primers. 4, 1\u201324 (2018).","journal-title":"Nat. Reviews Disease Primers"},{"key":"37569_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-83023-4","volume":"11","author":"G Feliciani","year":"2021","unstructured":"Feliciani, G. et al. The potential role of MR based radiomic biomarkers in the characterization of focal testicular lesions. Sci. Rep. 11, 1\u20139 (2021).","journal-title":"Sci. Rep."},{"key":"37569_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/PROM.S242754","volume":"12","author":"R Mercieca-Bebber","year":"2021","unstructured":"Mercieca-Bebber, R., Naher, S. K., Rincones, O., Smith, A. B. & Stockler, M. R. Patient-reported outcomes associated with treatments for testicular cancer: a systematic review. Patient Relat. Outcome Measures. 12, 129 (2021).","journal-title":"Patient Relat. Outcome Measures"},{"key":"37569_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/s24010037","volume":"24","author":"S Das","year":"2023","unstructured":"Das, S., Dey, M. K., Devireddy, R. & Gartia, M. R. Biomarkers in cancer detection, diagnosis, and prognosis. Sensors 24, 37 (2023).","journal-title":"Sensors"},{"key":"37569_CR7","doi-asserted-by":"publisher","first-page":"1557223","DOI":"10.3389\/fimmu.2025.1557223","volume":"16","author":"H Zhu","year":"2025","unstructured":"Zhu, H., Zhao, Y., Wang, Y., Wei, G. & Liu, J. Understanding the relationship between Cuproptosis and the development of hepatocellular carcinoma: implications for targeted therapies. Front. Immunol. 16, 1557223 (2025).","journal-title":"Front. Immunol."},{"key":"37569_CR8","doi-asserted-by":"publisher","first-page":"7448","DOI":"10.3390\/jcm13237448","volume":"13","author":"J Sykes","year":"2024","unstructured":"Sykes, J., Kaldany, A. & Jang, T. L. Current and evolving biomarkers in the diagnosis and management of testicular germ cell tumors. J. Clin. Med. 13, 7448 (2024).","journal-title":"J. Clin. Med."},{"key":"37569_CR9","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/andr.13337","volume":"11","author":"J Chavarriaga","year":"2023","unstructured":"Chavarriaga, J. & Hamilton, R. J. MiRNAs for testicular germ cell tumours: contemporary indications for diagnosis, surveillance and follow-up. Andrology 11, 628\u2013633 (2023).","journal-title":"Andrology"},{"key":"37569_CR10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/1354750X.2024.2361796","volume":"29","author":"N Lakpour","year":"2024","unstructured":"Lakpour, N. et al. Higher expression of SALL4-A isoform is correlated with worse outcomes and progression of the disease in subtype of testicular germ cell tumours. Biomarkers 29, 324\u2013339 (2024).","journal-title":"Biomarkers"},{"key":"37569_CR11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41746-025-01930-6","volume":"8","author":"Y Wang","year":"2025","unstructured":"Wang, Y., Zhu, H., Ren, J. & Ren, M. Integrative machine learning models predict prostate cancer diagnosis and biochemical recurrence risk: advancing precision oncology. NPJ Digit. Med. 8, 524 (2025).","journal-title":"NPJ Digit. Med."},{"key":"37569_CR12","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12672-025-02093-2","volume":"16","author":"J Gu","year":"2025","unstructured":"Gu, J., Wang, Y., Zhang, H., Gu, H. & Zhu, H. SIGLEC1 has the potential to be an immune-related prognostic indicator in colon adenocarcinoma: a study based on transcriptomic data and Mendelian randomization analysis. Discover Oncol. 16, 324 (2025).","journal-title":"Discover Oncol."},{"key":"37569_CR13","doi-asserted-by":"publisher","first-page":"1573815","DOI":"10.3389\/fimmu.2025.1573815","volume":"16","author":"Y Chen","year":"2025","unstructured":"Chen, Y. et al. ALDOC promotes neuroblastoma progression and modulates sensitivity to chemotherapy drugs by enhancing aerobic Glycolysis. Front. Immunol. 16, 1573815 (2025).","journal-title":"Front. Immunol."},{"key":"37569_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev.biophys.050708.133744","volume":"38","author":"DR Critchley","year":"2009","unstructured":"Critchley, D. R. Biochemical and structural properties of the integrin-associated cytoskeletal protein Talin. Annual Rev. Biophys. 38, 235\u2013254 (2009).","journal-title":"Annual Rev. Biophys."},{"key":"37569_CR15","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.str.2010.07.011","volume":"18","author":"PR Elliott","year":"2010","unstructured":"Elliott, P. R. et al. The structure of the Talin head reveals a novel extended conformation of the FERM domain. Structure 18, 1289\u20131299 (2010).","journal-title":"Structure"},{"key":"37569_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/B978-0-12-386039-2.00004-3","volume":"289","author":"A Desiniotis","year":"2011","unstructured":"Desiniotis, A. & Kyprianou, N. Significance of Talin in cancer progression and metastasis. Int. Rev. cell. Mol. Biology. 289, 117\u2013147 (2011).","journal-title":"Int. Rev. cell. Mol. Biology"},{"key":"37569_CR17","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1158\/0008-5472.CAN-09-2833","volume":"70","author":"S Sakamoto","year":"2010","unstructured":"Sakamoto, S., McCann, R. O., Dhir, R. & Kyprianou, N. Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and Anoikis resistance. Cancer Res. 70, 1885\u20131895 (2010).","journal-title":"Cancer Res."},{"key":"37569_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1083\/jcb.201108078","volume":"196","author":"C Lawson","year":"2012","unstructured":"Lawson, C. et al. FAK promotes recruitment of Talin to nascent adhesions to control cell motility. J. Cell Biol. 196, 223\u2013232 (2012).","journal-title":"J. Cell Biol."},{"key":"37569_CR19","first-page":"3265","volume":"12","author":"JL Zhang","year":"2011","unstructured":"Zhang, J. L., Qian, Y. B., Zhu, L. X. & Xiong, Q. R. Talin1, a valuable marker for diagnosis and prognostic assessment of human hepatocelluar carcinomas. Asian Pac. J. Cancer Prev. 12, 3265\u20133269 (2011).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"37569_CR20","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/cas.13247","volume":"108","author":"P Chen","year":"2017","unstructured":"Chen, P. et al. Downregulation of Talin1 promotes hepatocellular carcinoma progression through activation of the ERK1\/2 pathway. Cancer Sci. 108, 1157\u20131168 (2017).","journal-title":"Cancer Sci."},{"key":"37569_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/path.2867","volume":"224","author":"MT Lai","year":"2011","unstructured":"Lai, M. T. et al. Talin-1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis. J. Pathol. 224, 367\u2013376 (2011).","journal-title":"J. Pathol."},{"key":"37569_CR22","doi-asserted-by":"publisher","first-page":"e4326","DOI":"10.1097\/MD.0000000000004326","volume":"95","author":"N Xu","year":"2016","unstructured":"Xu, N. et al. Upregulation of Talin-1 expression associates with advanced pathological features and predicts lymph node metastases and biochemical recurrence of prostate cancer. Medicine 95, e4326 (2016).","journal-title":"Medicine"},{"key":"37569_CR23","first-page":"2533","volume":"18","author":"O Bostanci","year":"2014","unstructured":"Bostanci, O. et al. A novel screening test for colon cancer: Talin-1. Eur. Rev. Med. Pharmacol. Sci. 18, 2533\u20132537 (2014).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"37569_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-015-1351-5","volume":"15","author":"YF Xu","year":"2015","unstructured":"Xu, Y. F. et al. High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma. BMC Cancer. 15, 1\u201310 (2015).","journal-title":"BMC Cancer"},{"key":"37569_CR25","doi-asserted-by":"publisher","first-page":"17786","DOI":"10.1038\/s41598-020-74810-6","volume":"10","author":"S Vafaei","year":"2020","unstructured":"Vafaei, S. et al. Low expression of Talin1 is associated with advanced pathological features in colorectal cancer patients. Sci. Rep. 10, 17786 (2020).","journal-title":"Sci. Rep."},{"key":"37569_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3233\/CBM-220018","volume":"35","author":"L Saeednejad Zanjani","year":"2022","unstructured":"Saeednejad Zanjani, L., Vafaei, S., Abolhasani, M., Fattahi, F. & Madjd, Z. Prognostic value of Talin-1 in renal cell carcinoma and its association with B7-H3. Cancer Biomarkers. 35, 269\u2013292 (2022).","journal-title":"Cancer Biomarkers"},{"key":"37569_CR27","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12885-023-10771-z","volume":"23","author":"Y Rezaie","year":"2023","unstructured":"Rezaie, Y. et al. High expression of Talin-1 is associated with tumor progression and recurrence in melanoma skin cancer patients. BMC Cancer. 23, 302 (2023).","journal-title":"BMC Cancer"},{"key":"37569_CR28","doi-asserted-by":"publisher","first-page":"312","DOI":"10.30699\/ijp.2023.554227.2901","volume":"18","author":"M Sharbatoghli","year":"2023","unstructured":"Sharbatoghli, M. et al. The association between higher expression of talin-1 and the reduced survival rate in ovarian serous carcinoma patients. Iran. J. Pathol. 18, 312 (2023).","journal-title":"Iran. J. Pathol."},{"key":"37569_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1080\/1354750X.2024.2423270","volume":"29","author":"F Hashemi","year":"2024","unstructured":"Hashemi, F. et al. Clinical significance of Talin-1 and HER-2 status in different types of gastric carcinoma. Biomarkers 29, 539\u2013556 (2024).","journal-title":"Biomarkers"},{"key":"37569_CR30","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.mpdhp.2021.04.004","volume":"27","author":"RC Chan","year":"2021","unstructured":"Chan, R. C., Chandra, A. & Varma, M. Clinical utility of histopathology data: cancers of the testis and urinary bladder. Diagn. Histopathology. 27, 290\u2013296 (2021).","journal-title":"Diagn. Histopathology"},{"key":"37569_CR31","doi-asserted-by":"publisher","unstructured":"Bremmer, F. et al. Proteomic comparison of malignant human germ cell tumor cell lines. Dis. Markers 2019 (8298524). https:\/\/doi.org\/10.1155\/2019\/8298524 (2019).","DOI":"10.1155\/2019\/8298524"},{"key":"37569_CR32","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1039\/c9mo00082h","volume":"15","author":"J Muntel","year":"2019","unstructured":"Muntel, J. et al. Surpassing 10 000 identified and quantified proteins in a single run by optimizing current LC-MS instrumentation and data analysis strategy. Mol. Omics. 15, 348\u2013360. https:\/\/doi.org\/10.1039\/c9mo00082h (2019).","journal-title":"Mol. Omics"},{"key":"37569_CR33","first-page":"1","volume":"16","author":"A Sadeghipour","year":"2025","unstructured":"Sadeghipour, A. et al. Increased nuclear expression of DNA damage inducible transcript 4 can serve as a potential prognostic biomarker in patients with gliomas: a study based on data mining and experimental tools. Discover Oncol. 16, 1\u201319 (2025).","journal-title":"Discover Oncol."},{"key":"37569_CR34","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00018-019-03022-7","volume":"76","author":"A Batool","year":"2019","unstructured":"Batool, A., Karimi, N., Wu, X. N., Chen, S. R. & Liu, Y. X. Testicular germ cell tumor: a comprehensive review. Cell. Mol. Life Sci. 76, 1713\u20131727 (2019).","journal-title":"Cell. Mol. Life Sci."},{"key":"37569_CR35","doi-asserted-by":"publisher","first-page":"e13998","DOI":"10.1111\/and.13998","volume":"53","author":"N Lakpour","year":"2021","unstructured":"Lakpour, N. et al. Potential biomarkers for testicular germ cell tumour: risk assessment, diagnostic, prognostic and monitoring of recurrence. Andrologia 53, e13998 (2021).","journal-title":"Andrologia"},{"key":"37569_CR36","first-page":"687","volume":"91","author":"S Matsumoto","year":"2000","unstructured":"Matsumoto, S., Matsuda, H., Uejima, S. & Kurita, T. Secondary leukemia following ultra high-dose chemotherapy with peripheral blood stem cell autotransplantation for refractory testicular cancer. Nihon Hinyokika Gakkai Zasshi Japanese J. Urol. 91, 687\u2013691 (2000).","journal-title":"Nihon Hinyokika Gakkai Zasshi Japanese J. Urol."},{"key":"37569_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000282992","volume":"58","author":"N Nonomura","year":"1997","unstructured":"Nonomura, N. et al. Secondary acute monocytic leukemia occurring during the treatment of a testicular germ cell tumor. Urol. Int. 58, 239\u2013242 (1997).","journal-title":"Urol. Int."},{"key":"37569_CR38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/CAD.0b013e3282f0777e","volume":"19","author":"A Azak","year":"2008","unstructured":"Azak, A., \u00d6ks\u00fczoglu, B., Deren, T., \u00d6ne\u00e7, B. M. & Zengin, N. Cerebrovascular accident during cisplatin-based combination chemotherapy of testicular germ cell tumor: an unusual case report. Anti-cancer Drugs. 19, 97\u201398 (2008).","journal-title":"Anti-cancer Drugs"},{"key":"37569_CR39","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1179\/joc.2010.22.2.134","volume":"22","author":"I Meattini","year":"2010","unstructured":"Meattini, I. et al. Ischemic stroke during cisplatin-based chemotherapy for testicular germ cell tumor: case report and review of the literature. J. Chemother. 22, 134\u2013136 (2010).","journal-title":"J. Chemother."},{"key":"37569_CR40","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.urology.2012.04.064","volume":"80","author":"NG Cost","year":"2012","unstructured":"Cost, N. G. et al. Effect of testicular germ cell tumor therapy on renal function. Urology 80, 641\u2013648 (2012).","journal-title":"Urology"},{"key":"37569_CR41","doi-asserted-by":"crossref","unstructured":"Cerrud-Rodriguez, R. C., Quinteros, M. G. & Azam, M. Internal carotid artery occlusion and stroke as a complication of cisplatin-based chemotherapy for metastatic testicular germ cell tumour. Case Rep. bcr-2017-220084 (2017).","DOI":"10.1136\/bcr-2017-220084"},{"key":"37569_CR42","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4161\/cam.20488","volume":"6","author":"C Lawson","year":"2012","unstructured":"Lawson, C. & Schlaepfer, D. Integrin adhesions: who\u2019s on first? What\u2019s on second? Cell Adhes. Migr. 6, 302\u2013306 (2012).","journal-title":"Cell Adhes. Migr."},{"key":"37569_CR43","doi-asserted-by":"publisher","first-page":"e1004593","DOI":"10.1371\/journal.pcbi.1004593","volume":"11","author":"J Zhou","year":"2015","unstructured":"Zhou, J. et al. Mechanism of focal adhesion kinase mechanosensing. PLoS Comput. Biol. 11, e1004593 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"37569_CR44","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nrc1568","volume":"5","author":"JW Oosterhuis","year":"2005","unstructured":"Oosterhuis, J. W. & Looijenga, L. H. Testicular germ-cell tumours in a broader perspective. Nat. Rev. Cancer. 5, 210\u2013222 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"37569_CR45","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1016\/j.celrep.2018.05.039","volume":"23","author":"H Shen","year":"2018","unstructured":"Shen, H. et al. Integrated molecular characterization of testicular germ cell tumors. Cell. Rep. 23, 3392\u20133406 (2018).","journal-title":"Cell. Rep."},{"key":"37569_CR46","first-page":"105","volume":"67","author":"ES De Brito Gomes","year":"2025","unstructured":"De Brito Gomes, E. S. et al. Epithelial-mesenchymal plasticity and cisplatin resistance in germ cell tumors: mechanisms and emerging therapeutic strategies. Int. J. Oncol. 67, 105 (2025).","journal-title":"Int. J. Oncol."},{"key":"37569_CR47","doi-asserted-by":"publisher","first-page":"1269637","DOI":"10.3389\/fonc.2023.1269637","volume":"13","author":"G M\u0142ynarczyk","year":"2023","unstructured":"M\u0142ynarczyk, G., Domian, N. & Kasacka, I. Changes in adhesion molecules: \u03b2-catenin, E-cadherin and Galectin-3 in cells of testicular seminoma. Front. Oncol. 13, 1269637 (2023).","journal-title":"Front. Oncol."},{"key":"37569_CR48","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.7314\/APJCP.2014.15.6.2655","volume":"15","author":"KP Fang","year":"2014","unstructured":"Fang, K. P., Zhang, J. L., Ren, Y. H. & Qian, Y. B. Talin-1 correlates with reduced invasion and migration in human hepatocellular carcinoma cells. Asian Pac. J. Cancer Prev. 15, 2655\u20132661 (2014).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"37569_CR49","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.5858\/2007-131-1267-AOOTGC","volume":"131","author":"A Bahrami","year":"2007","unstructured":"Bahrami, A., Ro, J. Y. & Ayala, A. G. An overview of testicular germ cell tumors. Arch. Pathol. Lab. Med. 131, 1267\u20131280 (2007).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"37569_CR50","doi-asserted-by":"crossref","unstructured":"Brummel, K., Eerkens, A. L., de Bruyn, M. & Nijman, H. W. Tumour-infiltrating lymphocytes: from prognosis to treatment selection. British J. Cancer 1\u20138 (2022).","DOI":"10.1038\/s41416-022-02119-4"},{"key":"37569_CR51","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/PAI.0000000000001220","volume":"32","author":"SA Jazi","year":"2024","unstructured":"Jazi, S. A. et al. Higher expression of Talin-1 is associated with less aggressive tumor behavior in pancreatic cancer. Appl. Immunohistochem. Mol. Morphology. 32, 425\u2013435 (2024).","journal-title":"Appl. Immunohistochem. Mol. Morphology"},{"key":"37569_CR52","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar, R., Domrachev, M. & Lash, A. E. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207\u2013210. https:\/\/doi.org\/10.1093\/nar\/30.1.207 (2002).","journal-title":"Nucleic Acids Res."},{"key":"37569_CR53","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gkv1145","volume":"44","author":"JA Vizca\u00edno","year":"2016","unstructured":"Vizca\u00edno, J. A. et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. 44, D447\u2013D456 (2016).","journal-title":"Nucleic Acids Res."},{"key":"37569_CR54","doi-asserted-by":"publisher","unstructured":"Sun, L. et al. DiVenn: an interactive and integrated Web-Based visualization tool for comparing gene lists. Front. Genet. 10 https:\/\/doi.org\/10.3389\/fgene.2019.00421 (2019).","DOI":"10.3389\/fgene.2019.00421"},{"key":"37569_CR55","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"37569_CR56","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1007\/s00432-020-03319-2","volume":"146","author":"M Shahin","year":"2020","unstructured":"Shahin, M. et al. Low level expression of human telomerase reverse transcriptase predicts cancer-related death and progression in embryonal carcinoma. J. Cancer Res. Clin. Oncol. 146, 2753\u20132775 (2020).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"37569_CR57","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12957-025-03681-w","volume":"23","author":"S Rahmani","year":"2025","unstructured":"Rahmani, S. et al. Cytoplasmic SALL4-A isoform expression as a diagnostic marker of less aggressive tumor behavior in gastric cancer. World J. Surg. Oncol. 23, 41 (2025).","journal-title":"World J. Surg. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37569-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37569-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37569-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:06:50Z","timestamp":1771506410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37569-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37569"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37569-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the Iran University of Medical Sciences Human Research, Iran (Ref no: IR.IUMS.REC.1399.1189). All procedures performed in this study were conducted in accordance with the 1964 Helsinki Declaration and its subsequent amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"6557"}}